13.01.2013 Views

Calcium-Binding Protein Protocols Calcium-Binding Protein Protocols

Calcium-Binding Protein Protocols Calcium-Binding Protein Protocols

Calcium-Binding Protein Protocols Calcium-Binding Protein Protocols

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Monitoring Ca 2+ -Calmodulin Concentration 373<br />

Fmax – F [CaM] tot<br />

————— = —————— (1)<br />

Fmax – Fmin [CaM] tot – Kd If Michaelis-Menten conditions do not apply, then the data must be fit to Eq. 2.<br />

Fmax – F [I] tot – [CaM] tot – Kd – √([I] tot + [CaM] tot + Kd) 2 – 4[I] tot[CaM] tot<br />

————— = —————————————————————————— (2)<br />

Fmax – Fmin 1[I] tot<br />

For example, FIP-CB SM–35 has a K d of 1 nM for Ca 2+ –CaM, but in our hands, 2 nM<br />

is the minimum indicator concentration producing acceptable fluorescence data.<br />

Thus, over most of the range of added CaM concentrations the bound and free<br />

concentrations of the protein are quite different, so a quadratic is required to fit<br />

the data (see Eq. 2). A drawback to using Eq. 2 is that it requires a precise knowledge<br />

of the indicator concentration, so it is important to perform titrations at two<br />

or three different indicator concentrations to ensure that consistent results are<br />

obtained. In addition, we should emphasize that little useful information about<br />

binding can be extracted from an essentially linear isotherm, such as would be<br />

obtained if we were to titrate the response of FIP-CB SM–35 at a concentration of<br />

100 nM. <strong>Binding</strong> data are fit directly to Eq. 1 or 2 using a standard nonlinear<br />

least-squares analysis. F max and F min are fluorescence emission measurements<br />

made at the acceptor (EYFP) emission maximum (approx 530 nm) when the indicator<br />

is CaM-free and CaM-saturated, respectively. [I] tot and [CaM] tot are the<br />

total concentrations of indicator and CaM (see Table 1).<br />

3.2. Stable Expression of Indicators in Mammalian Cells<br />

The procedures described here have been developed using HEK-293 cells, a<br />

line derived from human embryonic kidney epithelium (ATCC #1573). To construct<br />

mammalian expression vectors indicators, we simply excise the DNA<br />

encoding it from the bacterial expression vector using BamHI and XhoI and<br />

ligate the fragment into a pcDNA3 vector (Invitrogen, Inc., Carlsbad, CA)<br />

cleaved with these enzymes. Expression of the cloned indicator in these vectors<br />

is under control of a cytomegalovirus (CMV) promoter, and a nonfusion<br />

protein is produced. The supplier provides variants of this vector that carry<br />

selectable markers for zoecin, G418 or blasticidin. A vector map for the construct<br />

used to express FIP-CB SM–35 is shown in Fig. 2.<br />

3.2.1. Transfection and Selection to Produce HEK–293 Cells<br />

Stably-Expressing CaM Indicators<br />

LipofectAMINE ® (Life Technologies, Inc., Gaithersburg, MD) is used to introduce<br />

vector DNA into HEK-293 cells essentially as described by the manufacturer.<br />

1. Cells are plated at a density of 5 × 10 5 per 60-mm dish 2 d before transfection.<br />

Cells should be 50–80% confluent at the time of transfection.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!